Some links may earn us a commission; our work is independent.

Cataplexy: Symptoms, Diagnosis, and Treatment

Cataplexy causes brief, emotion-triggered loss of muscle tone while awareness is preserved. Learn what an episode can look like, what can mimic it, and how specialists diagnose and treat it.

Woman reacting with sudden surprise while using a laptop

The short version

  • Cataplexy is a brief, involuntary loss of muscle tone during wakefulness, usually triggered by emotion, while the person remains conscious.
  • It most often occurs with narcolepsy type 1, but fainting, seizures, functional neurologic episodes, and other causes of weakness or falls can look similar.
  • New collapse, loss of consciousness, one-sided weakness, injury, or uncontrolled episodes during safety-sensitive activities need prompt medical assessment.

Cataplexy is a sudden, involuntary reduction or loss of muscle tone while a person is awake. An episode is usually triggered by emotion, often laughter or amusement, and awareness is preserved. The person may be unable to speak or move normally, but they have not fainted and are not simply falling asleep 1 2.

Cataplexy can be subtle. It may cause the eyelids or jaw to droop, the voice to become weak, the head to fall forward, or the knees to buckle. A generalized episode can make the whole body slump or fall. Similar-looking events have many possible causes, so one episode of weakness during laughter is not enough to diagnose cataplexy or narcolepsy.

What a cataplexy episode can look like

Most episodes are brief, often lasting seconds and usually less than two minutes. Muscle tone then returns without the prolonged confusion that may follow some seizures. The pattern differs from person to person and can vary within the same person 1 2.

Partial cataplexy

Partial attacks affect a limited group of muscles. Possible signs include:

  • Drooping eyelids or facial slackness
  • A weak or slurred voice
  • Jaw or neck weakness
  • Head nodding
  • Objects slipping from the hands
  • Brief knee buckling without a complete fall

Someone may still be able to sit, lean against a stable surface, or communicate with eye movements. These features are not unique to cataplexy, and a clinician needs to consider their timing and context.

Generalized cataplexy

In a generalized attack, loss of tone affects much of the body. The person may slump into a chair or fall to the floor and be unable to speak or move for a short time. Consciousness is normally preserved. A report of blacking out, losing time, or remaining confused afterward points away from typical cataplexy and needs a broader evaluation 3.

Breathing continues during a typical episode. Eye movements are also preserved, although drooping eyelids can make the person appear asleep. Longer or repeated attacks can occur, particularly after a medication change, but they are atypical and should not be self-diagnosed 2.

Emotional triggers are common, but not identical for everyone

Laughter and joking are the classic triggers. Excitement, surprise, pride, anger, and frustration can also trigger attacks. The emotional link may be obvious in one episode and subtle in another. Some people with an established diagnosis also have atypical attacks without a clear trigger 1.

The useful question is not simply, “Did this happen while laughing?” A specialist looks for a repeatable pattern across the trigger, muscles involved, duration, preserved awareness, recovery, and other symptoms of narcolepsy. Avoiding laughter, relationships, or enjoyable activities is not a sound treatment plan. The aim is to control attacks and reduce injury risk without asking a person to suppress normal emotion.

Cataplexy is not the same as fainting, a seizure, or sleep paralysis

A sudden fall is sometimes called a “drop attack,” but that term describes an event rather than its cause. The comparison below shows why the surrounding details matter 3 1.

Event Typical setting and clues How it differs from classic cataplexy
Cataplexy Brief loss of tone while awake, commonly after laughter or another strong emotion Awareness is preserved, and recovery is usually rapid
Fainting, or syncope Lightheadedness, dimming vision, nausea, warmth, pallor, or a trigger such as standing may precede a collapse Consciousness is lost because blood flow to the brain briefly falls
Epileptic seizure May involve altered awareness, a stereotyped sequence, unusual movements, or confusion after the event The emotional trigger and preserved awareness of classic cataplexy are absent or unclear
Drop attack A sudden fall with several possible neurologic, cardiac, balance, or sleep-related causes It is a description, not a diagnosis
Persistent or periodic weakness Weakness may last hours or days, follow exertion, or involve a progressive neuromuscular pattern Cataplexy is brief and tied to a wakeful episode rather than sustained loss of strength
Functional neurologic episode Real, involuntary weakness or collapse that may have a variable or prolonged pattern Diagnosis relies on positive clinical features assessed by an experienced clinician, not on assuming symptoms are imagined 4
Sleep paralysis Inability to move while falling asleep or waking It occurs at a sleep-wake transition rather than during ordinary wakefulness after an emotional trigger
REM sleep behavior disorder Dream-enactment movements and vocalizations occur during REM sleep when normal REM muscle atonia is reduced It occurs during sleep and involves movement, not emotion-triggered loss of tone while awake 5

These distinctions are guides, not home diagnostic rules. For example, brief movements can occur during fainting, and not every seizure produces obvious shaking or prolonged confusion. A clinician may need cardiac, neurologic, or sleep testing based on the full event.

How cataplexy relates to narcolepsy type 1

Cataplexy occurs overwhelmingly in narcolepsy type 1. This disorder also causes persistent excessive daytime sleepiness and may include fragmented nighttime sleep, sleep paralysis, and vivid hallucinations as sleep begins or ends. A person does not need every symptom to have narcolepsy.

Most people with narcolepsy type 1 have marked deficiency of hypocretin, also called orexin, a signaling system that helps stabilize wakefulness and muscle tone. Cataplexy appears to recruit part of the brain circuitry that normally suppresses muscle tone during rapid eye movement (REM) sleep, but during an attack the person remains awake and conscious. The exact sequence that produces an attack is still being studied 2.

Cataplexy outside narcolepsy type 1 is uncommon. Similar syndromes have been reported with rare genetic or metabolic disorders and with lesions affecting hypothalamic or brainstem pathways. Sudden onset alongside other neurologic changes, or a cataplexy-like pattern without persistent daytime sleepiness, gives a clinician more reason to look for another cause 3.

How cataplexy and narcolepsy are diagnosed

Diagnosis starts with the story of the events, not with one laboratory number.

A sleep specialist may ask:

  • What emotion or situation came just before the episode?
  • Which muscles became weak, and in what order?
  • Could you hear, remember, breathe, or move your eyes normally?
  • How long did the weakness and recovery last?
  • Was there sleepiness, lightheadedness, a racing heart, unusual movement, or confusion?
  • How often does it happen, and has the pattern changed?
  • Which medicines, supplements, alcohol, or other substances are involved?

A short home video can be particularly useful if it can be recorded without delaying care or putting anyone at risk. A symptom diary can show patterns in triggers, duration, and medication timing. Neither one confirms the diagnosis by itself 3.

Overnight polysomnography and the MSLT

An overnight polysomnogram records sleep stages, breathing, movement, and other signals. It can identify another sleep disorder and provides the overnight study that usually precedes a Multiple Sleep Latency Test (MSLT). The next-day MSLT measures how quickly a person falls asleep during scheduled naps and whether REM sleep begins unusually soon.

Under the current International Classification of Sleep Disorders criteria, objective findings used in the narcolepsy type 1 pathway can include:

  • An MSLT mean sleep latency of 8 minutes or less with at least two sleep-onset REM periods
  • In the appropriate cataplexy context, a sleep-onset REM period within 15 minutes on the overnight polysomnogram
  • Cerebrospinal fluid hypocretin-1 below the assay-defined diagnostic threshold 6

These results are interpreted with persistent daytime sleepiness, the clinical history, and possible alternative explanations. “REM within 15 minutes” is not a general definition of a positive MSLT, and no single finding confirms every case.

Test preparation matters. Insufficient sleep, shift work, an untreated sleep disorder, substances, and medicines that alter sleepiness or REM can distort an MSLT. AASM protocol recommends documenting sleep with a diary and, when available, actigraphy for two weeks beforehand. Medication changes and washout periods must be planned with the clinician because abrupt withdrawal can both harm the patient and produce misleading REM rebound 7.

Cerebrospinal fluid and other tests

Hypocretin-1 is measured in cerebrospinal fluid obtained by lumbar puncture. It can be especially useful when the clinical picture is difficult to interpret or a valid MSLT cannot be obtained. It is not a routine blood test.

HLA genetic markers are associated with narcolepsy type 1, but they also occur in people without narcolepsy and are not part of the objective ICSD-3-TR routes above. A positive HLA result does not confirm cataplexy, and a clinician cannot confirm the diagnosis with an autoimmune antibody blood panel 6 2. An electrocardiogram, heart monitoring, blood work, imaging, EEG, or other testing may be appropriate when the history raises a different cause of collapse or weakness.

Treatment targets cataplexy and sleepiness separately

Narcolepsy treatment is individualized around the symptoms causing disability, other health conditions, interactions, pregnancy plans, age, and the risks of treatment. A medicine that improves wakefulness does not necessarily control cataplexy 8 9.

Treatment approach Main symptom target Important boundary
Oxybate medicines Cataplexy and excessive daytime sleepiness These are powerful central nervous system depressants, and product-specific dosing, storage, interaction, and distribution rules matter
Pitolisant Cataplexy and excessive daytime sleepiness Heart-rhythm risk, liver or kidney function, interacting medicines, and contraception can affect whether it is appropriate
Certain antidepressants, often SNRIs or tricyclics Cataplexy, generally used off-label in the United States Evidence and approval vary, and missed doses or rapid withdrawal can cause rebound cataplexy
Wake-promoting medicines and stimulants Excessive daytime sleepiness Several improve alertness but should not be assumed to control cataplexy
Planned naps and a stable sleep schedule Daytime sleepiness and daily function These can support a treatment plan, but they are not established substitutes for cataplexy treatment

AASM strongly recommends pitolisant and sodium oxybate for adult narcolepsy based on evidence across narcolepsy outcomes. In the guideline's evidence review, both showed clinically meaningful improvement in cataplexy when it was present. European guidance also separates treatments for excessive daytime sleepiness from those for moderate to severe cataplexy, and it includes selected antidepressants among cataplexy options 8 9.

Product choice and availability vary by country. Oxybate formulations also differ in their ingredients and dosing schedules, so they should not be interchanged or adjusted without exact prescriber and pharmacy instructions.

Interactions and abrupt withdrawal matter

Oxybate is contraindicated with alcohol and sedative-hypnotic medicines. Combining it with opioids, benzodiazepines, sedating antidepressants or antipsychotics, muscle relaxants, anesthetics, or other central nervous system depressants can increase the risk of profound sedation, low blood pressure, breathing suppression, fainting, and death 10.

Pitolisant can prolong the QT interval in susceptible people, interacts with medicines that affect its metabolism or heart rhythm, and can reduce the effectiveness of hormonal contraception. Its current U.S. label advises nonhormonal contraception during treatment and for a specified period after stopping 11.

Antidepressants that suppress cataplexy need a planned taper when they are changed. Sudden discontinuation can produce a marked return of attacks and, rarely, long sequences of attacks called status cataplecticus. Do not skip, stop, or taper a cataplexy medicine to prepare for a sleep test, pregnancy, or any other reason without the prescribing clinician 9 7.

Reducing injury without avoiding normal emotion

If you recognize the start of an attack, sit or lie down away from traffic, stairs, hot surfaces, sharp objects, or water. People nearby can clear hazards, protect your head from a fall, and speak calmly. They should not restrain you or put anything in your mouth. A known, typical attack should resolve on its own, but an event that differs from your usual pattern should be treated cautiously.

Review safety at home, work, school, and during recreation. The most useful changes depend on the attacks. They may include seated tasks, guarded equipment, a safer route around stairs, avoiding unprotected heights, and not swimming or bathing alone while episodes are uncontrolled. A brief written plan can tell family, teachers, or coworkers that awareness is usually preserved and what would make the episode an emergency.

Driving and safety-sensitive work

Both cataplexy and excessive daytime sleepiness can make driving, biking in traffic, cooking, or operating machinery dangerous. AASM quality measures call for safety counseling at diagnosis and follow-up because symptoms and treatment response change over time 12.

Do not drive or perform a safety-sensitive task when attacks or sleepiness are uncontrolled. Ask the treating specialist for an individualized fitness-to-drive assessment and check the reporting and licensing rules where you live. A normal-feeling day, a symptom diary, or one alertness test cannot guarantee driving safety 13.

Work and school support

Cataplexy can be mistaken for inattention, intoxication, clumsiness, or a behavioral problem. A clear response plan and reasonable adjustments can reduce both injury and stigma. Depending on the person, useful measures may include scheduled breaks or naps for sleepiness, permission to sit during high-risk tasks, extra transition time, and an agreed procedure after an attack. The plan should distinguish a brief, familiar cataplexy episode from an event that needs emergency help.

Cataplexy can look different in children

Children may show the familiar pattern of brief weakness during laughter, but early cataplexy can also include persistent facial slackness, eyelid drooping, tongue protrusion, unusual mouth movements, head dropping, or an unsteady gait. The trigger may be less clear than it is in adults. Daytime sleepiness may appear as irritability, hyperactivity, declining school performance, or unusually long sleep 1 14.

These signs overlap with seizures, movement disorders, behavioral conditions, and other neurologic problems. A pediatric sleep specialist or neurologist should evaluate them. Medication evidence, approvals, dosing, and monitoring differ by age and jurisdiction, so an adult treatment plan should not be adapted for a child without specialist care 8 9.

Pregnancy, breastfeeding, and contraception require planning

Evidence for narcolepsy medicines during pregnancy and breastfeeding is limited, while untreated sleepiness and cataplexy can create fall, driving, and caregiving risks. Preconception planning should involve the sleep specialist and obstetric clinician so they can weigh the exact medicine, symptom severity, alternatives, and exposure timing 9.

Do not abruptly stop an antidepressant or another narcolepsy medicine after a positive pregnancy test. A planned change reduces rebound cataplexy and other withdrawal risks. Ask specifically about contraception interactions because pitolisant and some wake-promoting medicines can reduce the effectiveness of hormonal methods 11 8.

When to get urgent help

Call emergency services for an episode with:

  • Loss of consciousness, trouble breathing, or inability to wake normally
  • New one-sided weakness, facial asymmetry, severe headache, or new trouble speaking or seeing
  • Chest pain, a racing or irregular heartbeat, or collapse during exertion
  • A serious head injury, heavy bleeding, or another major injury
  • Prolonged confusion, repeated convulsive movements, or a first suspected seizure

Contact the treating clinician promptly if attacks suddenly become frequent or prolonged, occur without the usual pattern, cause falls, or worsen after a missed dose or medication change. Stop driving and other high-risk activities until the change has been assessed.

Bottom line

Cataplexy is a brief loss of muscle tone during wakefulness, usually linked to emotion, with consciousness preserved. Partial attacks can be easy to miss, while generalized attacks can resemble fainting or a seizure. The diagnosis depends on the complete pattern and an appropriate narcolepsy evaluation, not on laughter, knee buckling, a home video, or one test result alone.

Treatment should map to the symptom. Oxybate medicines and pitolisant can help both cataplexy and daytime sleepiness for some people, selected antidepressants are used mainly for cataplexy, and several wake-promoting medicines primarily address sleepiness. A sleep specialist can build a plan that controls attacks while accounting for interactions, withdrawal, driving, work or school, age, and pregnancy.

Sources

Evidence cited in this article.

14 sources
  1. What is cataplexy? (opens in a new tab)
    SleepResearch
    ↩
  2. Cataplexy: clinical aspects, pathophysiology and management strategy (opens in a new tab)
    Nature Reviews NeurologyResearch
    ↩
  3. Cataplexy and Its Mimics: Clinical Recognition and Management (opens in a new tab)
    Current Treatment Options in NeurologyResearch
    ↩
  4. Diagnosis and management of functional neurological disorder (opens in a new tab)
    The BMJResearch
    ↩
  5. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline (opens in a new tab)
    Journal of Clinical Sleep MedicineResearch
    ↩
  6. International Classification of Sleep Disorders, Third Edition, Text Revision: Summary of Diagnostic Criteria Changes (opens in a new tab)
    American Academy of Sleep MedicineProfessional guidance
    ↩
  7. Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine (opens in a new tab)
    Journal of Clinical Sleep MedicineResearch
    ↩
  8. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline (opens in a new tab)
    Journal of Clinical Sleep MedicineResearch
    ↩
  9. European guideline and expert statements on the management of narcolepsy in adults and children (opens in a new tab)
    European Journal of NeurologyResearch
    ↩
  10. Sodium Oxybate Oral Solution Prescribing Information (opens in a new tab)
    DailyMedOfficial product information
    ↩
  11. WAKIX (pitolisant) Prescribing Information (opens in a new tab)
    DailyMedOfficial product information
    ↩
  12. Quality measures for care of patients with narcolepsy: 2025 update after measure maintenance (opens in a new tab)
    American Academy of Sleep MedicineProfessional guidance
    ↩
  13. Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy (opens in a new tab)
    Therapeutics and Clinical Risk ManagementResearch
    ↩
  14. Pediatric Narcolepsy: A Practical Review (opens in a new tab)
    ChildrenResearch
    ↩

Keep reading

More on Narcolepsy

Open Narcolepsy →